Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
2.510
+0.060 (2.45%)
At close: Jul 11, 2025, 4:00 PM
2.590
+0.080 (3.19%)
After-hours: Jul 11, 2025, 6:59 PM EDT

Galectin Therapeutics Market Cap

Galectin Therapeutics has a market cap or net worth of $158.86 million as of July 11, 2025. Its market cap has increased by 14.62% in one year.

Market Cap
158.86M
Enterprise Value
259.86M
1-Year Change
14.62%
Ranking
Category
Stock Price
$2.51

Market Cap Chart

Created with Highcharts 11.4.8Range1 Month1M6 Months6MYear to DateYTD1 Year1Y3 Years3Y5 Years5Y10 Years10YFull HistoryMax9 Sep 200211 Jul 2025Max ▾200420062008201020122014201620182020202220240100M200M300M159M

Since September 9, 2002, Galectin Therapeutics's market cap has increased from $31.60M to $158.86M, an increase of 402.73%. That is a compound annual growth rate of 7.32%.

History

DateMarket Cap% Change
Jul 11, 2025158.90M96.17%
Dec 31, 202481.00M-21.13%
Dec 29, 2023102.70M52.83%
Dec 30, 202267.20M-45.28%
Dec 31, 2021122.80M-3.99%
Dec 31, 2020127.90M-21.39%
Dec 31, 2019162.70M15.31%
Dec 31, 2018141.10M18.57%
Dec 29, 2017119.00M313.19%
Dec 30, 201628.80M-26.53%
Dec 31, 201539.20M-48.96%
Dec 31, 201476.80M-48.11%
Dec 31, 2013148.00M352.60%
Dec 31, 201232.70M-55.81%
Dec 30, 201174.00M32.14%
Dec 31, 201056.00M288.89%
Dec 31, 200914.40M234.88%
Dec 31, 20084.30M-84.81%
Dec 31, 200728.30M111.19%
Dec 29, 200613.40M-83.91%
Dec 30, 200583.30M21.96%
Dec 31, 200468.30M-23.94%
Dec 31, 200389.80M72.69%
Dec 31, 200252.00M64.56%
View and export this data all the way back to 2002. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 704.75B
Johnson & Johnson 377.73B
AbbVie 339.41B
Novo Nordisk 316.64B
UnitedHealth Group 273.17B
Novartis AG 243.81B
Abbott Laboratories 229.54B
AstraZeneca 223.49B
Market Cap Rankings